Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid removal from human serum samples.

A R Castro1, W E Morrill, V Pope

  • 1Division of AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. ajc5@cdc.gov

Clinical and Diagnostic Laboratory Immunology
|March 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MPT64 patch test for the diagnosis of active pulmonary tuberculosis: a randomised controlled trial in Peru.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2018
Same author

Production of added value bacterial lipids through valorisation of hydrocarbon-contaminated cork waste.

The Science of the total environment·2017
Same author

Buschke-Ollendorff syndrome: a novel case series and systematic review.

The British journal of dermatology·2015
Same author

An immunofiltration device for the simultaneous detection of non-treponemal and treponemal antibodies in patients with syphilis.

Sexually transmitted infections·2010
Same author

Emotional aspects of chronic orofacial pain and surgical treatment.

International journal of surgery (London, England)·2009
Same author

The Met Office Hadley Centre climate modelling capability: the competing requirements for improved resolution, complexity and dealing with uncertainty.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2007
Same journal

Longitudinal analysis of Severe Acute Respiratory Syndrome (SARS) coronavirus-specific antibody in SARS patients.

Clinical and diagnostic laboratory immunology·2005
Same journal

Immunoglobulin E binding reactivity of a recombinant allergen homologous to alpha-Tubulin from Tyrophagus putrescentiae.

Clinical and diagnostic laboratory immunology·2005
Same journal

Unidirectional suppression of Anaplasma phagocytophilum genotypes in infected lambs.

Clinical and diagnostic laboratory immunology·2005
Same journal

Long-term follow-up of Hepatitis B Surface antibody levels in subjects receiving universal Hepatitis B vaccination in infancy in an area of hyperendemicity: correlation between radioimmunoassay and enzyme immunoassay.

Clinical and diagnostic laboratory immunology·2005
Same journal

Gamma interferon is dispensable for neopterin production in vivo.

Clinical and diagnostic laboratory immunology·2005
Same journal

Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51.

Clinical and diagnostic laboratory immunology·2005
See all related articles

Cleanascite HC effectively removes lipids from human serum, comparable to chloroform but with greater ease and fewer environmental risks. It minimally impacts antibody reactivity in syphilis serologic tests.

Area of Science:

  • Clinical Chemistry
  • Biochemistry

Background:

  • Lipid interference can affect serologic test accuracy.
  • Traditional lipid removal methods, like chloroform, pose environmental and safety concerns.

Purpose of the Study:

  • To evaluate Cleanascite HC as an alternative lipid removal agent for human serum.
  • To compare its efficacy and impact on serologic testing against the standard chloroform method.

Main Methods:

  • Human serum samples were treated with Cleanascite HC or chloroform.
  • Lipid content was measured pre- and post-treatment.
  • Antibody reactivity in syphilis serologic tests was assessed after Cleanascite HC treatment.

Main Results:

  • Cleanascite HC removed 61-70% of lipids, comparable to chloroform (60-62%).

Related Experiment Videos

  • Cleanascite HC demonstrated procedural simplicity and reduced environmental concerns.
  • Minimal loss of antibody reactivity was observed in syphilis serologic tests.

    • Conclusions:

    • Cleanascite HC is an effective and safer alternative for lipid reduction in human serum.
    • It offers a practical solution for improving sample quality in diagnostic testing.